Adastra hires Hybrid Financial for marketing services

Adastra Holdings Ltd. is pleased to announce that it has retained Hybrid Financial Ltd. to provide marketing services to the Company.

ADASTRA HOLDINGS LTD. ENGAGES HYBRID FINANCIAL LTD.

Adastra Holdings Ltd. (formerly Phyto Extractions Inc.) (CSE: XTRX) (FRA: D2EP) (“Adastra”, or the “Company”) is pleased to announce that it has retained Hybrid Financial Ltd. (“Hybrid”) to provide marketing services to the Company. Hybrid has been engaged to heighten market and brand awareness for Adastra and to broaden the Company’s reach within the investment community.

Hybrid has agreed to comply with all applicable securities laws and the policies of the Canadian Securities Exchange in providing the services.

Hybrid has been engaged by the Company for an initial period of six (6) months starting May 3, 2021 (the “Initial Term”) and then shall be renewed automatically for successive three (3) month periods thereafter, unless terminated by the Company in accordance with the agreement. Hybrid will be paid a monthly fee of $22,500, plus applicable taxes, during the Initial Term.

About Adastra Holdings Ltd.:

Founded in 2018 and formerly known as Phyto Extractions Inc., Adastra is a leading manufacturer and supplier of innovative ethnobotanical and cannabis science products designed for the adult-use and medical markets and forward-looking therapeutic applications. Adastra is renowned throughout Canada for its popular line of Phyto Extractions branded cannabis concentrate products available on shelves at over 1,400 adult-use retailers across the country. The Company also operates Adastra Labs, a 13,500 sq. ft. agricultural-scale Health Canada licensed facility located in Langley, BC., focused on extraction, distillation, and manufacturing of cannabis-derived products. Adastra has now successfully taken the first steps in becoming a licensed cultivator, tester, extractor, and seller of controlled substances, including Psilocybin, Psilocin, MDMA, N, N-Dimethyltryptamine (DMT), 5- MeO-DMT, and LSD by applying for a Controlled Substances Dealer’s Licence, which is under review by Health Canada. Pending Health Canada approval, Adastra is poised to be a drug formulation and development leader in this emerging sector. In addition, with the recent acquisition of 1225140 B.C. Ltd., doing business as PerceiveMD, Adastra operates a multidisciplinary centre for medical cannabis and psychedelic therapies, working alongside doctors and healthcare professionals within the regulated environment to help create efficacious remedies that address the actual needs of patients.

About Hybrid Financial Ltd.:

Hybrid is a sales and distribution company that actively connects issuers to the investment community across North America. Using a data driven approach, Hybrid provides its clients with comprehensive coverage of both American and Canadian markets. Hybrid has offices in Toronto and Montreal.

ON BEHALF OF THE BOARD

ADASTRA HOLDINGS LTD. (CSE: XTRX)

Donald Dinsmore, Chief Operating Officer

P: (778) 715-5011, E: Donald@adastralabs.com

Cody Simpson, Communications Manager

P: (778) 715-5011, E: cody@adastraholdings.ca

The Canadian Securities Exchange has not reviewed or approved the contents of this news release.

Source

Click here to connect with Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) for an Investor Presentation

Featured
Boreal Metals Corp.   announces it has changed its name to Norden Crown Metals Corp. in accordance with the provisions of the Business Corporations Act . Norden Crown Metals Corp's name reflects the next stage of the new management's corporate strategy, focused on mineral exploration for precious and base metals in "Norden" Scandinavia. The Company's ticker symbol on the TSX-V will be changed to "NOCR."  The name ...

Boreal Metals Corp. (TSXV: BMX) ( Frankfurt : 03E) (OTCQB: BORMF) announces it has changed its name to Norden Crown Metals Corp. ("the Company") (TSXV: NOCR) in accordance with the provisions of the Business Corporations Act ( British Columbia ).

read more Show less
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Cronos Group Inc. resulting from allegations that Cronos may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Cronos securities you may be entitled to compensation without payment of any out of pocket fees or costs ...

-

read more Show less
Cohen Milstein Sellers & Toll PLLC today announced that its ongoing investigation has led to the filing of a class action complaint against Bristol-Myers Squibb Company and several of its senior executives and directors. The case was filed in the United States District Court for the Southern District of New York, Case No. 21-cv-10351The action was brought on behalf of all former Celgene Corporation shareholders that ...

Cohen Milstein Sellers & Toll PLLC ("Cohen Milstein") today announced that its ongoing investigation has led to the filing of a class action complaint against Bristol-Myers Squibb Company ("Bristol Myers") and several of its senior executives and directors. The case was filed in the United States District Court for the Southern District of New York, Case No. 21-cv-10351

The action was brought on behalf of all former Celgene Corporation ("Celgene") (CELG) shareholders that received Contingent Value Rights ("CVRs") in exchange for their Celgene shares pursuant to Bristol Myers' $74 billion acquisition of Celgene on November 20, 2019, and were damaged thereby, and all persons who purchased CVRs between November 20, 2019 and December 31, 2020 (the "Class Period"), and who were damaged thereby (the "Class").

read more Show less

MARKETS

Markets
TSX20633.27-128.76
TSXV897.13-13.09
DOW34580.08-59.71
S&P 5004538.43-38.67
NASD15085.47-295.85
ASX7241.20+16.00

COMMODITIES

Commodities
Gold1783.44+1.06
Silver22.54+0.03
Copper4.27-0.03
Palladium1816.01+10.01
Platinum936.31+3.31
Oil66.22-0.28
Heating Oil2.10-0.01
Natural Gas4.09+0.04